| Teduglutide for the treatment of short bowel syndrome. | |
| | |
MedLine Citation:
|
PMID: 22017694 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Extensive resection of the intestine impairs its absorptive capacity and results in short bowel syndrome when the nutritional equilibrium is compromised. The remnant intestine adapts structurally to compensate, but nutritional autonomy cannot be achieved in patients with intestinal failure, requiring intravenous fluids and parenteral nutrition (PN) for sustenance of life. PN is expensive and associated with serious complications. Efforts to minimize or eliminate the need for PN heralded research focusing on the therapeutic utility of intrinsic gut factors involved in the postresection adaptation process. With the breakthrough recognition of the intestinotrophic properties of glucagon-like peptide-2, teduglutide, a recombinant analogue of glucagon-like peptide-2, is being investigated as a promising hope to mitigate the requirement of PN. Clinical studies to date have demonstrated a desirable benefit-to-risk profile in regards to its safety and efficacy. If approved for marketing, it will be the first of its class in short bowel syndrome management, offering an innovative therapeutic modality for this debilitating condition. |
| | |
Authors:
|
Kishore Vipperla; Stephen J O'Keefe |
Related Documents
:
|
12432194 - Concomitant acral necrosis and haemolytic uraemic syndrome following ingestion of quinine. 59334 - Recurrent haemolytic uraemic syndrome. 9210084 - Successful interferon therapy in a neonate with life-threatening kasabach-merritt syndr... 2486474 - Radiation-induced oesophageal stricture in a case of bloom's syndrome. 12699424 - Biased t-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrom... 20502924 - Lumbopelvic stabilization with external fixator in a patient with lumbosacral agenesis. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Expert review of gastroenterology & hepatology Volume: 5 ISSN: 1747-4132 ISO Abbreviation: Expert Rev Gastroenterol Hepatol Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-10-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278199 Medline TA: Expert Rev Gastroenterol Hepatol Country: England |
Other Details:
|
Languages: eng Pagination: 665-78 Citation Subset: IM |
Affiliation:
|
Division of General Internal Medicine, University of Pittsburgh Medical Center, 200 Lothrop Street, 933W MUH, Pittsburgh, PA 15213, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Estriol has different effects from 17?-estradiol in modulating mouse splenocyte function under infla...
Next Document: Adalimumab for the treatment of inflammatory bowel disease.